Past, present and prospect of retroperitoneal tumor surgery

doi:10.16139/j.1007-9610.2022.06.02

Abstract

CLC Number:

R735.4

CHEN Jun, LUO Chenghua. Past, present and prospect of retroperitoneal tumor surgery[J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 490-494.

References 22

[1]	DeSantis CE, Kramer JL, Jemal A. The burden of rare cancers in the United States[J]. CA Cancer J Clin, 2017, 67(4):261-272. doi: 10.3322/caac.21400 URL
[2]	Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy[J]. Cancer, 2006, 106(7):1610-1616. doi: 10.1002/cncr.21761 pmid: 16518798
[3]	Matsuda T, Won YJ, Chun-Ju Chiang R, et al. Rare cancers are not rare in Asia as well: the rare cancer burden in East Asia[J]. Cancer Epidemiol, 2020, 67:101702. doi: 10.1016/j.canep.2020.101702 URL
[4]	中华医学会肿瘤学分会, 中华医学会杂志社, 中国医师协会肛肠医师分会腹膜后疾病专业委员会, 等. 中国腹膜后肿瘤诊治专家共识(2019版)[J]. 中华肿瘤杂志, 2019, 41(10):728-733.
[5]	Donnelly BA. Primary retroperitoneal tumors; a report of 95 cases and a review of the literature[J]. Surg Gynecol Obstet, 1946, 83(6):705-717.
[6]	HJ W. Primary retroperitoneal sarcoma[J]. Am J Med Sci, 1903, 126:269-276. doi: 10.1097/00000441-190308000-00007 URL
[7]	Judd ES. Retroperitoneal tumors[J]. S Clin North Am, 1933,823.
[8]	Haas R, Stelmes JJ, Zaffaroni F, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: results from the EORTC 62092-22092 STRASS trial[J]. Cancer, 2022, 128(14):2796-2805. doi: 10.1002/cncr.34239 pmid: 35536104
[9]	Pack GT, Tabah EJ. Primary retroperitoneal tumors: a study of 120 cases[J]. Int Abstr Surg, 1954, 99(4):313-341. pmid: 13205424
[10]	Cody HS 3rd, Turnbull AD, Fortner JG, et al. The continuing challenge of retroperitoneal sarcomas[J]. Cancer, 1981, 47(9):2147-2152. pmid: 7226108
[11]	Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma[J]. Ann Surg, 1991, 214(1):2-10. doi: 10.1097/00000658-199107000-00002 pmid: 2064467
[12]	孟承伟, 胡永昌. 原发性腹膜后肿瘤:64例分析[J]. 中华外科杂志, 1960, 8(6)547-550.
[13]	陈凛, 李荣, 石怀银, 等. 原发性腹膜后肿瘤600例临床研究[J]. 中国肿瘤, 2003, 12(10):611-613.
[14]	Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients[J]. J Clin Oncol, 2009, 27(1):24-30. doi: 10.1200/JCO.2008.17.8871 pmid: 19047283
[15]	Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control[J]. J Clin Oncol, 2009, 27(1):31-37. doi: 10.1200/JCO.2008.18.0802 pmid: 19047280
[16]	Callegaro D, Miceli R, Brunelli C, et al. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma[J]. Br J Surg, 2015, 102(9):1079-1087. doi: 10.1002/bjs.9829 pmid: 26041724
[17]	Gronchi A, Miceli R, Colombo C, et al. Frontline exten-ded surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas[J]. Ann Oncol, 2012, 23(4):1067-1073. doi: 10.1093/annonc/mdr323 pmid: 21765179
[18]	MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the Transatlantic RPS Wor-king Group[J]. Ann Surg, 2018, 267(5):959-964. doi: 10.1097/SLA.0000000000002250 pmid: 28394870
[19]	Casali PG, Abecassis N, Aro HT, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl 4):iv268-iv269. doi: 10.1093/annonc/mdy321 URL
[20]	Istl AC, Gronchi A. Neoadjuvant therapy for primary resectable retroperitoneal sarcomas-looking forward[J]. Cancers(Basel), 2022, 14(7):1831.
[21]	Dickson MA, Tap WD, Keohan ML, et al. Phase Ⅱ trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma[J]. J Clin Oncol, 2013, 31(16):2024-2028. doi: 10.1200/JCO.2012.46.5476 pmid: 23569312
[22]	Mahmood ST, Agresta S, Vigil CE, et al. Phase Ⅱ study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous his-tiocytoma[J]. Int J Cancer, 2011, 129(8):1963-1969. doi: 10.1002/ijc.25843 pmid: 21154746

Past, present and prospect of retroperitoneal tumor surgery

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 22

Related Articles 10

Recommended Articles

Metrics

Comments

[1]	LIU Wenshuai, LU Weiqi, ZHOU Yuhong. Management of retroperitoneal sarcoma: rule, dilemma and perspectives-detailed interpretation of CSCO Guideline [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 483-489.
[2]	LI Chengpeng, HAO Chunyi. Considerations for promoting clinical research on retroperitoneal sarcoma in China [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 495-499.
[3]	WANG Jian. Retroperitoneal tumor: pathological diagnosis and differential diagnosis [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 500-505.
[4]	WANG Zheng, BAO Cihang, JIANG Guoliang. Value of proton and heavy ion radiotherapy in treatment of retroperitoneal sarcoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 506-510.
[5]	DING Yuqin, SHI Hongcheng, JI Zhengbiao. Imaging in diagnosis and treatment of retroperitoneal tumor: application and expert consensus interpretation [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 511-516.
[6]	YANG Chuanxin, WANG Jian. Concept of precision surgery in standardization and safety during surgical treatment of retroperitoneal tumor [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 517-520.
[7]	XIE Fuan, REN Yantao, LI Wengang. Study on retroperitoneal liposarcoma: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 521-525.
[8]	QIU Fabo, ZHOU Bin, QU Pengfei. Surgical standard and quality control for retroperitoneal tumor [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 526-529.
[9]	PAN Xiangou, ZHANG Li, HOU Jiazhou, DU Shisuo, ZENG Zhaochong, WANG Binliang. Study on preoperative radiotherapy in conversion therapy for patients with primary retroperitoneal soft tissue sarcoma difficult to resect or unresectable [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 530-533.
[10]	ZHUANG Aobo, TONG Hanxing, ZHANG Yong, LU Weiqi, ZHOU Yuhong, LÜ Chentao. Safety analysis on surgical treatment of elderly patients with primary retroperitoneal soft tissue sarcoma: a retrospective cohort study [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 534-539.